Dr. Shaad Essa Abedin, FACP, MD

Dr. Abedin practices at Mary Washington Hospital in Fredericksburg, Virginia, part of Mary Washington Healthcare.

Dr. Abedin's NPI, 1669676250, was assigned on June 14, 2007. Dr. Abedin graduated from Dow University of Health Sciences in 2004. Dr. Abedin holds Virginia license 0101252823.

Dr. Abedin's primary practice is Mary Washington Hospital, at 1001 Sam Perry Boulevard, Fredericksburg, VA 22401 in Fredericksburg City. The practice phone is (540) 741-1100.

Dr. Abedin's primary practice is Mary Washington Hospital in Fredericksburg, Virginia, part of Mary Washington Healthcare. The medical group on file is Mary Washington Healthcare. Dmand AI also links Dr. Abedin to 2 more medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Abedin practices, 2 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Abedin's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Abedin is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Abedin's licenses on file in 4 states: Virginia, District of Columbia, Maryland and Florida.

CMS data shows 22 Medicare services from Dr. Abedin across 1 procedure code in 2024, for 21 Medicare patients. Medicare paid $1,320 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 21 Medicare patients who saw Dr. Abedin in 2024. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 2.82, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Abedin's median patient age at 64, with 57% women.

In 2017, Dr. Abedin wrote 23 Medicare Part D claims. Every claim was for a generic drug. They cover 2 drugs, with $187 in total drug cost. In 2016, CMS named 130 claims across 9 drugs.

Dr. Abedin accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 2 papers to Dr. Abedin in 2025. The most frequent topics are Melanoma. Dr. Abedin's most frequent co-authors are Todd Michael Bauer, MD, Volkan Beylergil, MD and Richard D. Carvajal, MD.

CMS Open Payments shows 63 general payments to Dr. Abedin from 17 drug and device companies from 2016 to 2024. Honoraria make up the largest share, 40% of the total. Alexion Pharmaceuticals, Inc. paid the most, $17,156.

Dmand AI lists 3 awards for Dr. Abedin, most recently Fellow in 2015.

Dr. Abedin graduated from Dow University of Health Sciences in 2004. Dr. Abedin is a member of ACP, ASCO and ASH.